Zobrazeno 1 - 10
of 27
pro vyhledávání: '"J. P. Michiel Sedelaar"'
Autor:
Maria V. Luna‐Velez, Jelmer J. Dijkstra, Marina A. Heuschkel, Frank P. Smit, Guillaume van de Zande, Dominique Smeets, J. P. Michiel Sedelaar, Michiel Vermeulen, Gerald W. Verhaegh, Jack A. Schalken
Publikováno v:
Molecular Oncology, Vol 15, Iss 7, Pp 1882-1900 (2021)
Bladder urothelial cell carcinoma (UCC) incidence is about three times higher in men compared with women. There are several indications for the involvement of hormonal factors in the aetiology of UCC. Here, we provide evidence of androgen signalling
Externí odkaz:
https://doaj.org/article/232b1f170c384ea19e66163c0f81904f
Autor:
Sofie C. M. Tops, Evert L. Koldewijn, Diederik M. Somford, Anita M. P. Huis, Eva Kolwijck, Heiman F. L. Wertheim, Marlies E. J. L. Hulscher, J. P. Michiel Sedelaar
Publikováno v:
BMC Urology, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background The clinical landscape of prostate biopsy (PB) is evolving with changes in procedures and techniques. Moreover, antibiotic resistance is increasing and influences the efficacy of pre-biopsy prophylactic regimens. Therefore, increa
Externí odkaz:
https://doaj.org/article/a975e9c10fc04995b102ad107775131a
Autor:
Anouk Anna Maria Arnoldus van der Aa, Christophe Koenraad Mannaerts, Maudy C. W. Gayet, Johannes Cornelis van der Linden, Barthold Philip Schrier, J. P. Michiel Sedelaar, Massimo Mischi, Harrie P. Beerlage, Hessel Wijkstra
Publikováno v:
BMC Urology, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background To overcome the limitations regarding two dimensional (2D) greyscale (GS) transrectal ultrasound (TRUS)-guided biopsy in prostate cancer (PCa) detection and tissue packaging in biopsy processing, there is an ongoing focus on new i
Externí odkaz:
https://doaj.org/article/0fc7dbd4164c4fe0bcb9c30208d0e9f7
Autor:
Jeroen H. A. Creemers, Maarten J. van der Doelen, Sandra van Wilpe, Rick Hermsen, Tjitske Duiveman-de Boer, Diederik M. Somford, Marcel J. R. Janssen, J. P. Michiel Sedelaar, Niven Mehra, Johannes Textor, Harm Westdorp
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundRadium-223 improves overall survival (OS) in men with bone metastatic castration-resistant prostate cancer (mCRPC). While the exact mechanism behind this survival benefit remains unclear, radium-induced immunological mechanisms might contri
Externí odkaz:
https://doaj.org/article/9681b271f3804ad081b66ebff52e0e79
Autor:
Ellen Kampman, Alina Vrieling, Katja K H Aben, Lambertus A L M Kiemeney, Jake S F Maurits, J P Michiel Sedelaar, DKE van derSchoot, AQHJ Niemer, DM Somford, WA Scheepens, PJM Kil, BP Wijsman, PJ van Hest, DM Bochove-Overgaauw, S van derMeer, E van Boven, LMCL Fossion, K de Laet, FS van Rey, GAHJ Smits, ADH Geboers, WJ Kniestedt, RP Meijer, MDH Kortleve, S Stomps
Publikováno v:
BMJ Open, Vol 13, Iss 3 (2023)
Purpose The Renal cell cancer: Lifestyle, prognosis and quality of life (ReLife) study is set up to obtain insight into the association of patient and tumour characteristics, lifestyle habits and circulating biomarkers with body composition features
Externí odkaz:
https://doaj.org/article/9356292fe7e4451c8267728ae88e9505
Autor:
Amina Banda, Bastiaan M. Privé, Youssra Allach, Maike J. M. Uijen, Steffie M. B. Peters, Cato C. Loeff, Martin Gotthardt, Constantijn H. J. Muselaers, J. Alfred Witjes, Inge M. van Oort, J. P. Michiel Sedelaar, Harm Westdorp, Niven Mehra, Fadi Khreish, Samer Ezziddin, Amir Sabet, Michael C. Kreissl, Thomas Winkens, Philipp Seifert, Marcel J. R. Janssen, Willemijn A. M. van Gemert, James Nagarajah
Publikováno v:
Cancers, 15, 1
Cancers, 15
Cancers; Volume 15; Issue 1; Pages: 297
Cancers, 15
Cancers; Volume 15; Issue 1; Pages: 297
Background: Prostate-specific membrane antigen (PSMA)-directed radioligand therapy (RLT) is a novel treatment for patients with castration-resistant prostate cancer (CRPC). Given the mode of action, patients in an earlier disease stage, such as hormo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13b3270a192735ebeaacacf62523afef
Autor:
Sofie C M Tops, Eva Kolwijck, Evert L Koldewijn, Diederik M Somford, Filip J M Delaere, Menno A van Leeuwen, Anthonius J Breeuwsma, Thijn F de Vocht, Hans J H P Broos, Rob A Schipper, Martijn G Steffens, Steven Teerenstra, Marjolijn C A Wegdam-Blans, Els de Brauwer, Wouter van den Bijllaardt, Alexander C A P Leenders, J P Michiel Sedelaar, Heiman F L Wertheim
Publikováno v:
Clinical Infectious Diseases, 76, 1188-1196
Clinical Infectious Diseases, 76, 7, pp. 1188-1196
Clinical Infectious Diseases, 76, 7, pp. 1188-1196
Background An increase in infections after transrectal prostate biopsy (PB), related to an increasing number of patients with ciprofloxacin-resistant rectal flora, necessitates the exploration of alternatives for the traditionally used empirical prop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9772edfb9f7e83f928debd998e484431
http://hdl.handle.net/2066/291773
http://hdl.handle.net/2066/291773
Autor:
Yvonne H. W. Derks, Melline G. M. Schilham, Mark Rijpkema, Esther M. M. Smeets, Helene I. V. Amatdjais-Groenen, Annemarie Kip, Sanne A. M. van Lith, Jill van de Kamp, J. P. Michiel Sedelaar, Diederik M. Somford, Michiel Simons, Peter Laverman, Martin Gotthardt, Dennis W. P. M. Löwik, Sandra Heskamp, Susanne Lütje
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 50, 9, pp. 2872-2884
Purpose Incomplete resection of prostate cancer (PCa) results in increased risk of disease recurrence. Combined fluorescence-guided surgery with tumor-targeted photodynamic therapy (tPDT) may help to achieve complete tumor eradication. We developed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7ecbc1450682f82ccc894d8216083a3
https://repository.ubn.ru.nl/handle/2066/294532
https://repository.ubn.ru.nl/handle/2066/294532
Autor:
Bastiaan M. Privé, Constantijn H. J. Muselaers, Inge M. van Oort, Marcel J. R. Janssen, Steffie M. B. Peters, Willemijn A. M. van Gemert, Maike J. M. Uijen, Melline M. G. Schilham, J. P. Michiel Sedelaar, Harm Westdorp, Niven Mehra, Martin Gotthardt, Jelle O. Barentsz, Winald R. Gerritsen, J. Alfred Witjes, James Nagarajah
Publikováno v:
Frontiers in Nuclear Medicine. 2
177Lu-PSMA-617 radioligand therapy is a novel treatment for end-stage prostate cancer, which could also be applied to patients with hormone-sensitive prostate cancer with high expression levels of prostate-specific membrane antigen (PSMA). In this pe
Autor:
Sofie C. M. Tops, Justin G. A. Grootenhuis, Anouk M. Derksen, Federica Giardina, Eva Kolwijck, Heiman F. L. Wertheim, Diederik M. Somford, J. P. Michiel Sedelaar
Publikováno v:
Journal of Urology, 208, 1, pp. 109-118
Journal of Urology, 208, 109-118
Journal of Urology, 208, 109-118
Contains fulltext : 251755.pdf (Publisher’s version ) (Open Access) PURPOSE: The aim of our study was to compare infectious complication rates between different prostate biopsy techniques with various number of biopsy cores. MATERIALS AND METHODS:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fb17d8eb71a150932a7370eda05424f
https://repository.ubn.ru.nl/handle/2066/251755
https://repository.ubn.ru.nl/handle/2066/251755